M Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
NRG Therapeutics
8 Sept 2025
NRG Therapeutics lands £50m Series B led by SV Health Investors to advance neurodegenerative disease therapies
NRG Therapeutics develops oral small-molecule drugs targeting mitochondrial dysfunction, aiming to slow or halt neurodegenerative diseases such as ALS and Parkinson’s through disease-modifying treatments.
TRIMTECH Therapeutics
5 Mar 2025
TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments
TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.
M Ventures
- 1(12 months)
- m-ventures.com
- Update Information
More venture news
- 18 Feb 2026
FYLD secures a £30m Series B led by Energy Impact Partners to monitor high-risk infrastructure fieldwork with intelligence platform
Series BIndustrial - 5 Feb 2026
LawhiveLawhive raises £45m Series B led by angel Mitch Rales to speed up legal services for consumers with AI
Series BLegal - 10 Feb 2026
TemTem lands £55m Series B led by Lightspeed Venture Partners to fix the energy market with transaction infrastructure
Series BEnergy
